India, Dec. 12 -- Lupin Ltd announced that its subsidiary, Lupin Manufacturing Solutions, has entered into a long-term strategic partnership with PolyPeptide Group AG to enhance and scale the supply chain for peptide-based active pharmaceutical ingredients (APIs).
PolyPeptide Group AG is a specialised CDMO focused on peptide and oligonucleotide APIs. Through this collaboration, the two companies aim to expand sourcing options and strengthen global peptide supply chains, particularly to meet the growing demand for APIs used in metabolic disease therapies, Lupin said in a regulatory filing.
Published by HT Digital Content Services with permission from Dion Global Solutions Limited....